Aarkstore.com | Pharmaceuticals || Early Toxicology: Markets and Approaches

Aarkstore announce a new report "Early Toxicology: Markets and Approaches" through its vast collection of market research report.

ListFree.org (Press Release) - Saturday, October 6th, 2012 -

Aarkstore.com announces, a new market research report is available in its vast collection:

Early Toxicology: Markets and Approaches

http://www.aarkstore.com/reports/Early-Toxicology-Markets-and-Approaches-6650.html

Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET. Toxicity determinations are an integral part of all aspects of drug discovery & development.

This report, Early Toxicology Markets and Approaches, focuses on markets for early toxicology testing services. The objective of this report is to focus the reader’s attention on the issues and opportunities related to early toxicology testing in drug discovery. It begins with an overview of drug discovery, ADMET, and early toxicology testing. It continues with some of the ways big pharmaceutical developers dealwith early toxicology. Several areas are covered, including:

For the purposes of reporting market size and growth forecasts, the report segments the market into the following:

· In Silico Approaches

o Databases

o Data Mining Tools

o Modeling

In Vitro Assays and Platforms

o Biochemical Assays

o Cellular Assays

o Instruments & Platforms

· In Vivo Testing

o Mice & Traditional Animals

o Zebrafish Models

o Other Animals

o Human Microdosing

· Early Tox Services

o In Silico Services

o In Vitro Services

o In Vivo Services

Market analysis in this report considers primarily the availabilityof products, number and type of clinical trials active, primary endpoints, anddevelopment of new products. The marketfocuses on the United States region and, where available, discusses the marketglobally. All sales are displayed at the manufacturers’ level in U.S.dollars. Although the sales figures aredisplayed at the manufacturers’ level, in many instances, this figurerepresents a close comparison to the retail level as many end users arepurchasing directly from the manufacturer.The base year is 2011, with forecasts provided for each year through 2016.

Table of Contents :

CHAPTER ONE: EXECUTIVE SUMMARY

Drug Discovery: A Complex Process
Viox
Baycol
Rezulin
FenPhen
Drug Development Summary
Scope and Methodology
Market Overview
Competitors

CHAPTER TWO: INTRODUCTION TO EARLY TOXICOLOGY

Overview
The Cost of Drug Development
The Role of Contract Research Organizations
Toxicology Measurement Issues
Alternative Approaches to Early Toxicity

CHAPTER THREE: PHARMA STRATEGIES AND TOXICOLOGY TACTICS

Overview
Abbott: Developing Their Own Tools
Bristol-Myers Squibb: Reducing Drug Attrition
Eli Lilly & Company: In Silico And In Vitro Methods
Glaxo Smithkline: Global Safety Board
Johnson &Johnson: Alliances And Biomarkers
Novartis: Modeling & Simulation
Pfizer: Collaborative Approach

More Related Reports :

Epigenetics: Applications for Pharmaceuticals and Diagnostics (Methylation, Histone Modification and miRNA expression)

The World Market for Transdermal Drug Delivery

Early Toxicology: Markets and Approaches

Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

DNA Sequencing Equipment and Services Markets, 3rd. Edition

Medical Imaging Markets: Molecular Imaging

Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

Markets for Electrostimulation Devices (Neurostimulation, Cardiac Rhythm Management, Fracture Healing and Others)

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

Medical Imaging Markets: Contrast Agents